Evidence map›Paper›PMID 33098024›Full record

Observational studyDigestive diseases and sciences2021

Impaired Quality of Life in Patients with Autoimmune Atrophic Gastritis.

Emanuela Miceli, Natascia Brondino, Marco Vincenzo Lenti, Michele Di Stefano, Martina Staiani, Francesca Zugnoni, Martina Pisati, Costanza Caccia Dominioni, Gino Roberto Corazza, Pierluigi Politi and 1 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Digestive diseases and sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Autoimmune gastritis: emerging insights and clinical management.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Emanuela MiceliFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Natascia BrondinoDepartment of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
Marco Vincenzo LentiFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Michele Di StefanoFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Martina StaianiFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Francesca ZugnoniFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Martina PisatiFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Costanza Caccia DominioniFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Gino Roberto CorazzaFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy.
Pierluigi PolitiDepartment of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.
Antonio Di SabatinoFirst Department of Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy. a.disabatino@smatteo.pv.it.ORCID 0000-0002-0302-8645
University of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutoimmune atrophic gastritis (AAG) leads to vitamin B12 deficiency that may manifest with neuropsychiatric disorders, such as emotional instability, cognitive deficits, depression, and personality changes.

aimsTo evaluate the quality of life (QoL) in patients with AAG and the interplay between QoL, psychopathological symptoms, and demographic factors.

methodsThis is an observational, cross-sectional study including 102 patients with AAG (mean age 62 ± 13 years), 100 with functional gastrointestinal disorders (mean age 38.3 ± 17 years), 100 with other chronic organic gastrointestinal diseases (mean age 50.9 ± 21.4 years), and 100 healthy controls (mean age 37.5 ± 18.9 years). The 36-Item Short Form Health Survey questionnaire (SF-36) and the General Health Questionnaire-12 were administered. The results of the scales were compared among the study groups. Linear regression analyses were fitted to identify independent predictors of QoL in AAG patients.

resultsQoL was significantly different among the four groups in all subdomains. In particular, the AAG group was significantly (P < 0.01) more impaired than the functional gastrointestinal disorder group in the physical functioning and it was significantly more impaired than the control group in all the quality of life subdomains with exception of vitality. Vitamin B12 serum level was a significant (P < 0.04) independent predictor of physical functioning.

conclusionsPatients with AAG have a decreased QoL compared to healthy controls, but in line with that of patients with organic gastrointestinal disorders. Physical component is responsible for worsening QoL. Vitamin B12 supplementation may positively affect patient's perception of body functioning.

Indexed as

Quality of LifeAdultAgedAutoimmune DiseasesCross-Sectional StudiesFemaleGastritis, AtrophicHumansMaleMiddle AgedRisk FactorsSurveys and QuestionnairesMental healthNeuropsychiatric disordersPhysical healthQuality of life

Identifiers

PMID33098024
OpenAlexW3094613440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.